ALK licenses rights to neffy®, the first approved adrenaline nasal spray for emergency treatment of allergic reactions (anaphylaxis)ALK licenses rights to neffy®, the first approved adrenaline nasal spray for emergency treatment of allergic reactions (anaphylaxis) GlobeNewswire
||
ALK (ALKB:DC / OMX: ALK B) today announced that it has entered into a strategic license agreement with US-based ARS Pharmaceuticals, Inc. (“ARS Pharma”, NASDAQ: SPRY). The agreement grants... 
CV Pad Brings 0G AI Alignment Node Sale to Investors, Providing Early Access to Pioneering Decentralized AI TechnologyCV Pad Brings 0G AI Alignment Node Sale to Investors, Providing Early Access to Pioneering Decentralized AI Technology GlobeNewswire
||
KUTAISI, Georgia, Nov. 09, 2024 (GLOBE NEWSWIRE) — CV Pad, a prominent launchpad for web3 projects, announces the sale of 0G Foundation’s AI Alignment Nodes, providing early adopters with... 
Corvus Pharmaceuticals Announces New Data Highlighting Potential of Ciforadenant to Overcome Immunotherapy Resistance in Metastatic Castration Resistant Prostate CancerCorvus Pharmaceuticals Announces New Data Highlighting Potential of Ciforadenant to Overcome Immunotherapy Resistance in Metastatic Castration Resistant Prostate Cancer GlobeNewswire
||
Data presented in an oral session at the Society for Immunotherapy of Cancer 39th Annual Meeting, where it was selected as a top 100 abstract BURLINGAME, Calif., Nov. 09,... Post TitlePost Title The Manila Times
||
Post Content Post TitlePost Title The Manila Times
||
Post Content Post TitlePost Title The Manila Times
||
Post Content Post TitlePost Title The Manila Times
||
Post Content 
Fate Therapeutics Highlights Cancer-selective, HER2-Targeting Profile of FT825 / ONO-8250 CAR T-cell Product Candidate for Treatment of Advanced Solid Tumors at 2024 SITC Annual MeetingFate Therapeutics Highlights Cancer-selective, HER2-Targeting Profile of FT825 / ONO-8250 CAR T-cell Product Candidate for Treatment of Advanced Solid Tumors at 2024 SITC Annual Meeting GlobeNewswire
||
Novel H2CasMab-2 Antigen Binding Domain Shown to Preferentially Target HER2 Expressed on Tumor Cells in Preclinical Studies Initial Low-Dose Cohort of FT825 / ONO-8250 as Monotherapy Shows Favorable Safety... 
BSP cited for Coin Deposit MachinesBSP cited for Coin Deposit Machines Philippine News Agency
||
THE Bangko Sentral ng Pilipinas said it had received another award from the International Association of Currency Affairs (IACA) for its rollout of Coin Deposit Machines (CoDMs). In a...